Martinez R. New trends in paracoccidioidomycosis epidemiology. J Fungi. 2017;3(31):1.
Colombo AL, Tobón A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol. 2011;49(8):785–98.
Restrepo A, Gómez BL, Tobón A, Paracoccidioidomycosis. Latin america’s own fungal disorder. Curr Fungal Infect Rep. 2012;6(4):303–11.
Giusiano G, Aguirre C, Vratnica C, Rojas F, Corallo T, Cattana ME, et al. Emergence of acute/subacute infant-juvenile paracoccidioidomycosis in Northeast argentina: effect of Climatic and anthropogenic changes? Med Mycol. 2019;57(1):30–7.
Giusiano G, Tracogna F, Santiso G, Rojas F, Messina F, Sosa V, et al. Clinical and demographic features of paracoccidioidomycosis in argentina: A multicenter study analysis of 466 cases. J Fungi. 2023;9(4):482.
Fabris LR, de Oliveira NG, Bortolomai BE, Batista LCF, Sobral MH, Ribeiro AA, et al. The effect of geoclimatic factors on the distribution of paracoccidioidomycosis in Mato Grosso do sul, Brazil. J Fungi. 2024;10(3):165.
Benko LMP, Vieira da Silva ME, de Falcão S, Freitas EMM, Calvet DFS, de Almeida GA. Paracoccidioidomycosis and pregnancy: A 40-year single-center cohort study in the endemic area of Rio de janeiro, Brazil. PLoS Negl Trop Dis. 2023;17(9):e0011645.
PubMed PubMed Central Google Scholar
World Health Organization (WHO). WHO fungal priority pathogens list to guide research, development and public health action. Geneva. 2022. pp. 1–48.
Wagner G, Moertl D, Glechner A, Mayr V, Klerings I, Zachariah C, et al. Paracoccidioidomycosis diagnosed in Europe—A systematic literature review. J Fungi. 2021;7(2):157.
Wilson MJ, Harding I, Borman AM, Johnson E, Miller R. Pulmonary endemic mycoses. Clin Med. 2024;24(1):100014.
Llenas-García J, González Beiro R, Ramos‐Rincón J, Wikman‐Jorgensen P. Imported systemic endemic mycoses in Spain 1997–2021: an analysis of a National hospital database. Mycoses. 2025;68(1):e70021.
PubMed PubMed Central Google Scholar
Gonzalez A, Hernandez O. New insights into a complex fungal pathogen: the case of paracoccidioides spp. Yeast. 2016;33(4):113–28.
Shikanai-Yasuda MA, Mendes RP, Colombo AL, de Queiroz-Telles F, Kono ASG, Paniago AMM, et al. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Rev Soc Bras Med Trop. 2017;50(5):715–40.
Benard G. An overview of the immunopathology of human paracoccidioidomycosis. Mycopathol. 2008;165(4–5):209–21.
Hahn RC, Hagen F, Mendes RP, Burger E, Nery AF, Siqueira NP, et al. Paracoccidioidomycosis: current status and future trends. Clin Microbiol Rev. 2022;35(4):e0023321.
González A, Restrepo A, Cano LE. Pulmonary immune responses induced in balb/c mice by paracoccidioides Brasiliensis conidia. Mycopathol. 2008;165(4–5):313–30.
Camacho E, Niño-Vega GA. Paracoccidioides spp.: virulence factors and Immune-Evasion strategies. Mediators Inflamm. 2017;2017:5313691.
PubMed PubMed Central Google Scholar
Marcos CM, de Oliveira HC, de Melo W, de CMA J, de Assato F, Scorzoni PA. L, Anti-Immune strategies of pathogenic Fungi. Front Cell Infect Microbiol 2016; Nov 15:6142.
de Castro LF, Ferreira MC, da Silva RM, Blotta MH, de Longhi SL, Mamoni LNA. Characterization of the immune response in human paracoccidioidomycosis. J Infect. 2013;67(5):470–85.
Calich VLG, Mamoni RL, Loures FV. Regulatory T cells in paracoccidioidomycosis. Virulence. 2019;10(1):810–21.
Burger E. Paracoccidioidomycosis protective immunity. J Fungi. 2021;7(2).
De Oliveira HC, Assato PA, Marcos CM, Scorzoni L, De Paula E, Silva ACAA, Da Silva J. F, Paracoccidioides-host interaction: an overview on recent advances in the paracoccidioidomycosis. Front Microbiol 2015 Nov 25:61319.
Thind SK, Taborda CP, Nosanchuk JD. Dendritic cell interactions with Histoplasma and paracoccidioides. Virulence. 2015;6(5):424–32.
CAS PubMed PubMed Central Google Scholar
Tristão FSM, Rocha FA, Carlos D, Ketelut-Carneiro N, Souza COS, Milanezi CM, et al. Th17-Inducing cytokines IL-6 and IL-23 are crucial for granuloma formation during experimental paracoccidioidomycosis. Front Immunol. 2017 Aug;21:8949.
Parise-Fortes MR, Pereira Da Silva MF, Sugizaki MF, Defaveri J, Montenegro MR, Soares AMVC, et al. Experimental paracoccidioidomycosis of the Syrian hamster: fungicidal activity and production of inflammatory cytokines by macrophages. Med Mycol. 2000;38(1):51–60.
Mamoni RL, Nouér SA, Oliveira SJ, Musatti CC, Rossi CL, Camargos ZP, et al. Enhanced production of specific IgG4, ige, IgA and TGF-β in Sera from patients with the juvenile form of paracoccidioidomycosis. Med Mycol. 2002;40(2):153–9.
Negroni R. Paracoccidioidomycosis (South American blastomycosis, lutz’s mycosis). Int J Dermatol. 1993;32(12):847–59.
Giusiano G. The Trojan horse model in paracoccidioides: A fantastic pathway to survive infecting human cells. Front Cell Infect Microbiol. 2021;11:10.
Fortes MRP, Miot HA, Kurokawa CS, Marques MEA, Marques SA. Immunology of paracoccidioidomycosis. Bras Dermatol. 2011;86(3):516–25.
Olszewski M, Zhang Y, Zeltzer S. Th1, Th2, and beyond: what we know about adaptive immunity for fungal infections. Int J Clin Rev. 2010;4(3):96–103.
Shikanai-yasuda MA, Mendes RP, Colombo AL, Queiroz-telles F, De, Satie A, Kono G, et al. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Rev Soc Bras Med Trop. 2017;50(5):715–40.
Mendes RP, Cavalcante R, de Marques S, Marques SA, Venturini MEA, Sylvestre J. TF, Paracoccidioidomycosis: current perspectives from Brazil. Open Microbiol J 2017; Oct 31:11:224–82.
Borghi M, Renga G, Puccetti M, Oikonomou V, Palmieri M, Galosi C, et al. Antifungal Th immunity: growing up in family. Front Immunol. 2014 Oct;15:5506.
Calich VLG, Kashino SS. Cytokines produced by susceptible and resistant mice in the course of paracoccidioides Brasiliensis infection. Braz J Med Biol Res. 1998;31(5):615–23.
Braga FG, Ruas LP, Pereira RM, Lima XT, Antunes E, Mamoni RL, et al. Functional and phenotypic evaluation of eosinophils from patients with the acute form of paracoccidioidomycosis. PLoS Negl Trop Dis. 2017;11(5):1–17.
Pereira RM, Bucaretchi F, Barison EDM, Hessel G, Tresoldi AT. Paracoccidioidomycosis in children: clinical presentation, follow-up and outcome. Rev Inst Med Trop S Paulo. 2004;46(3):127–31.
Goihman-Yahr M, Essenfeld-Yahr E, de Albornoz MC, Yarzábal L, de Gómez MH, San Martín B, et al. Defect of in vitro digestive ability of polymorphonuclear leukocytes in paracoccidioidomycosis. Infect Immun. 1980;28(2):557–66.
CAS PubMed PubMed Central Google Scholar
Milde R, Ritter J, Tennent GA, Loesch A, Martinez FO, Gordon S, et al. Multinucleated giant cells are specialized for Complement-Mediated phagocytosis and large target destruction. Cell Rep. 2015;13(9):1937–48.
CAS PubMed PubMed Central Google Scholar
Calvi SA, Peraçoli MTS, Mendes RP, Marcondes-Machado J, Fecchio D, Marques SA, et al. Effect of cytokines on the in vitro fungicidal activity of monocytes from paracoccidioidomycosis patients. Microbes Infect. 2003;5(2):107–13.
Alves CCS, Azevedo ALS, Rodrigues MF, Machado RP, Souza MA, Machado MA, et al. Cellular and humoral immune responses during intrathoracic paracoccidioidomycosis in balb/c mice. Comp Immunol Microbiol Infect Dis. 2009;32(6):513–25.
Franco M, Montenegro MR, Mendes RP, Marques SA, Dillon NL, Gerusa N. Paracoccidioidomycosis: a recently proposed classification of its clinical forms. 1987; 20(2):129–32.
Nishikaku AS, Molina RFS, Ribeiro LC, Scavone R, Albe BP, Cunha CS, et al. Nitric oxide participation in granulomatous response induced by Paracoccidioides Brasiliensis infection in mice. Med Microbiol Immunol. 2009;198(2):123–35.
Pagliari C, Fernandes ER, Guedes F, Alves C, Sotto MN. Role of mast cells as IL10 producing cells in paracoccidioidomycosis skin lesions. Mycopathol. 2006;162(5):331–5.
Comments (0)